Abstract
Increasing recent evidence suggests a key role of oligodendroglial injury and demyelination in the pathophysiology of Huntington's Disease (HD) and the transcription factor PPAR delta is critical for oligodendroglial regeneration and myelination. PPAR delta directly involves in the pathogenesis of HD and treatment with a brain-permeable PPAR delta-agonist (KD3010) alleviates its severity in mice. Erucic acid (EA) is also a PPAR delta-ligand omega 9 fatty acid which is highly consumed in Asian countries through ingesting cruciferous vegetables such as rapeseed (Brassica napus) and indian mustard (Brassica juncea). EA is also an ingredient of Lorenzo's oil employed in the medical treatment of adrenoleukodystrophy and can be converted to nervonic acid, a component of myelin. HD pathogenesis also involves oxidative and inflammatory injury and EA exerts antioxidative and antiinflammatory efficacies including inhibition of thrombin and elastase. Consumption of rapeseed, indian mustard, and Canola oils (containing EA) improves cognitive parameters in animal models, as well as treatment with pure EA. Moreover, erucamide, an endogenous EA-amide derivative regulating angiogenesis and water balance, exerts antidepressive and anxiolytic effects in mice. Hitherto, no study has investigated the therapeutic potential of EA in HD and we believe that it strongly merits to be studied in animal models of HD as a potential therapeutic.
Original language | English |
---|---|
Pages (from-to) | 1-9 |
Number of pages | 9 |
Journal | Metabolic Brain Disease |
Volume | 35 |
Issue number | 1 |
Early online date | 17 Oct 2019 |
DOIs | |
Publication status | Published - Jan 2020 |
Keywords
- Erucic acid
- PPAR-delta
- Huntington's disease
- FATTY-ACIDS
- LORENZOS OIL
- THROMBIN
- RAT
- ERUCAMIDE
- BRAIN
- ANTIOXIDANT
- CONVERSION
- CHILDHOOD
- KIDNEYS